A recent study reported reduced levels of IL-22 in the serum and follicular fluid of PCOS patients, in addition to the fact that IL-22 administration could help to improve insulin resistance, ovarian dysfunction, and infertility in intestinal bacteria or a prenatal AMH-induced PCOS mice model [137]. This evidence concerns the gene IL22 and polycystic ovary syndrome.